...
首页> 外文期刊>Risk Management and Healthcare Policy >The Clinicians’ Satisfaction with Clinical Pathway Implementation: Preliminary Development of an Assessment Scale in China
【24h】

The Clinicians’ Satisfaction with Clinical Pathway Implementation: Preliminary Development of an Assessment Scale in China

机译:临床医生对临床途径实施的满意度:中国评估规模的初步发展

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Purpose:To develop a satisfaction scale of Chinese clinicians with Clinical Pathway (CP) implementation and evaluate its validity, reliability and item discrimination.Materials and Methods:Literature review, in-person interviews, and Delphi were used to design the scale. Data were collected in two phases using random sampling on the spot and an online survey. In the first phase, data from 239 clinicians were investigated in exploratory factor analysis. In the second phase, 513 valid questionnaires were collected and used for confirmatory factor analysis.Results:The scale developed in this study has three dimensions (organization support, process identity, and effect perception) and a total of 21 items. Cronbach's alpha of each dimension was higher than 0.9. The 3-factor model had enough fitness (χ2/df = 5.602, NFI = 0.926, IFI = 0.938, CFI = 0.938, RFI = 0.914, TLI = 0.929, RMSEA = 0.095, RMR = 0.045). The standardized factor loadings of 21 variables were between 0.742 and 0.949. The average variance extracted (AVE) of each dimension was higher than 0.7, and the construct reliability (CR) of the dimensions was higher than 0.9. The Chi-square difference test results showed that the difference value between the unlimited and limited model of each two potential constructs was higher than 3.84 (P 0.001).Conclusion:The clinicians' satisfaction scale developed in this study has good construct validity, convergent validity, discriminant validity, internal consistency, and item discrimination. This suggests its usefulness as a tool to assess the satisfaction of clinicians in the implementation of CP in China.? 2021 Li et al.
机译:目的:开发中国临床医生的满意度,具有临床途径(CP)实施,并评估其有效性,可靠性和项目歧视。材料和方法:文献综述,人物访谈和德尔菲用于设计规模。使用当场的随机抽样和在线调查中分两看阶段收集数据。在第一阶段,在探索性因子分析中调查了来自239名临床医生的数据。在第二阶段,收集513个有效问卷并用于确认因子分析。结果:本研究中开发的规模有三个维度(组织支持,过程身份和效果感知),共有21项。 Cronbach的每个尺寸的alpha高于0.9。 3因子模型具有足够的健身(χ2/ dF = 5.602,NFI = 0.926,IFI = 0.938,CFI = 0.938,RFI = 0.914,TLI = 0.929,RMSEA = 0.095,RMR = 0.045)。 21变量的标准化因子载荷在0.742和0.949之间。每个尺寸的(AVE)提取的平均方差高于0.7,尺寸的构建性可靠性(Cr)高于0.9。 Chi-Square差异测试结果表明,每个两个电位构建体的无限和有限模型之间的差值高于3.84(P <0.001)。结论:本研究中开发的临床医生的满意度规模具有良好的构建有效性,收敛有效性,判别有效性,内部一致性和项目歧视。这表明它作为评估临床医生在中国实施CP的临床医生满意度的工具的实用性。 2021 Li等人。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号